fg-4592 and Pancreatic-Neoplasms

fg-4592 has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for fg-4592 and Pancreatic-Neoplasms

Article	Year
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer research, 2019, 05-01, Volume: 79, Issue:9 Topics: Animals; Apoptosis; Female; Glycine; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Transcription Factors; Tumor Suppressor Protein p53	2019

Article

Year

Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

Cancer research, 2019, 05-01, Volume: 79, Issue:9

Topics: Animals; Apoptosis; Female; Glycine; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Transcription Factors; Tumor Suppressor Protein p53

2019